PDL BioPharma, Inc. Debt Instrument, Face Amount
PDL BioPharma, Inc. had Debt Instrument, Face Amount of $14.80 million as of 2020-09-30, per its 10-Q filed 2020-11-13.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2020-11-13
- 2020-09-30: Debt Instrument, Face Amount $14.80M.
- 2020-06-30: Debt Instrument, Face Amount $14.80M.
- 2020-03-31: Debt Instrument, Face Amount $14.80M.
- 2019-09-30: Debt Instrument, Face Amount $150.00M.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2020-09-30 | $14.80M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $14.80M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $14.80M 10-Q · filed 2020-05-11 |
| 2019-09-30 | $150.00M 10-Q · filed 2019-11-06 |